We use cookies to help provide you with the best possible online experience. Learn more

Press releases

Hacettepe University Hospitals, Turkey, selects RayStation

Hacettepe University Hospitals, a leading Turkish academic hospital group, has chosen RayStation® as its treatment planning system. The Department of Radiation Oncology at Hacettepe is one of the most technologically advanced centers in the Euro-Asia region, with equipment including Varian and Elekta linacs, CyberKnife, brachytherapy and 4D-CT imaging.

The order was placed through Oncotech Medical Systems, RaySearch’s distribution partner in Turkey, with installation scheduled to take place during fall 2016. Functionality will include 3D-CRT, VMAT, IMRT, fallback planning, deformable registration and multi-criteria optimization.

Hacettepe University Hospitals aims to create an integrated radiation therapy center that will lead the way in providing advanced cancer treatment. An important step in achieving this is to unify its broad range of treatment technology under a single treatment planning system. RayStation makes this possible through outstanding flexibility and support for all the latest treatment techniques and machines.

Professor Gokhan Ozyigit, Chairman of the Department of Radiation Oncology at Hacettepe University Hospitals, says: “The radiation therapy community tends to focus on treatment machines rather than software. I believe we must change that focus for the wellbeing of our patients. RayStation will be our backbone platform for various types of radiation therapy machines. The unique and advanced features of this powerful tool will enable a machine-independent environment and give us a new approach and direction for the future of radiation therapy.”

Mecit Canbolat, General Manager of Oncotech Medical Systems, says: “Hacettepe University Hospitals is one of the best-known such facilities in Turkey and a leading innovator in radiation therapy. RayStation is the perfect match for a department that needs to consolidate such a wide range of machines. This cooperation will help improve treatment quality for patients and should inspire other clinics.”

Johan Löf, CEO of RaySearch, says: “We have designed RayStation to meet the needs of leading-edge clinics like Hacettepe University Hospitals, which work with advanced techniques and often have systems from different providers. Software is driving innovation in radiation therapy today, and RayStation is at the forefront of the transformation. It helps to unify technology, opens up new treatment possibilities and provides the best possible user experience for clinicians.”

About Hacettepe University Hospitals
Founded in 1966, Hacettepe University Hospitals has a leading position in medical education in Turkey and is highly respected internationally. Hacettepe is today among the preeminent healthcare centers in Turkey. It comprises four hospitals that provide modern medical services to patients from all over Turkey. Hacettepe Oncology Hospital is one of the most prestigious cancer centers worldwide. The Department of Radiation Oncology treats more than 2,500 patients per year.

About RayStation
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.

More information about RaySearch is available at www.raysearchlabs.com

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00